NDC 50419-541

Kerendia

Finerenone

Kerendia is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Bayer Healthcare Pharmaceuticals Inc.. The primary component is Finerenone.

• Product ID: 50419-541_882a7626-242a-4450-87f4-45745e95a349
• NDC: 50419-541
• Product Type: Human Prescription Drug
• Proprietary Name: Kerendia
• Generic Name: Finerenone
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2021-07-09
• Marketing Category: NDA /
• Application Number: NDA215341
• Labeler Name: Bayer Healthcare Pharmaceuticals Inc.
• Substance Name: FINERENONE
• Active Ingredient Strength: 20 mg/1
• Pharm Classes: Mineralocorticoid Receptor Antagonists [MoA], Nonsteroidal Mineralocorticoid-Receptor Antagonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 50419-541-01

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-541-01)

• Marketing Start Date: 2021-07-09
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Kerendia" or generic name "Finerenone"

NDC	Brand Name	Generic Name
50419-540	Kerendia	finerenone
50419-541	Kerendia	finerenone